
Sponsorship & Exhibits
The TERMIS 2021 World Congress offers great opportunities to both commercial and non-commercial organizations, allowing them to showcase their products and services.
The TERMIS 2021 World Congress is the premier scientific event for Tissue Engineering and Regenerative Medicine in 2021. There are no continental chapter TERMIS meetings in that year.
Please apply to exhibit and sponsorship and:
- Present your business to an international premier scientific event for Tissue Engineering en Regenerative Medicine 2021.
- Get in front and meet new customers – explore new business opportunities
- Promote/market your business/services
For questions with regard to the exhibition and sponsorships, please contact the Congress Secretariat:
Klinkhamer Group | conferences & events
Ms. Nadia Debie
Tel.: +31 43 362 7008
Email: info@termis2021.org
Please note: all catering, posters and exhibitors are combined in one hall.
Stand 4: Dunn Labortechnik GmbH |
Rousselot At Rousselot we have drawn upon our 130 years of worldwide expertise and a proven track record of pharmaceutical gelatins to develop X-Pure®. A range of purified gelatins specifically designed for (bio)medical applications. X-Pure is the first complete range of highly purified gelatins with endotoxin levels below 10 EU/g. Endotoxins are pyrogens and when present in a biomaterial can cause febrile responses. Endotoxins are extremely resistant to temperature and difficult to remove by conventional methods. Thanks to Rousselot®’s proprietary purification process, X pure has shown to have a reduced pyrogenic activity reducing potential immune reactions. Discover X-Pure GelMA, the latest addition to X-Pure portfolio Rousselot Biomedical is committed to facilitating the use of X-Pure in your applications and to help you “Advance medical science”. With a proven track record of gelatin and collagen specifically used in pharmaceutical applications, Rousselot is recognized for its global expertise. Website: www.rousselot.com/biomedical |
Manchester BIOGEL |
Manchester BIOGEL is a leader in the design and manufacture of 3D synthetic peptide hydrogels that are redefining cell culture and 3D bioprinting for life science. Our biologically relevant PeptiGels® and PeptiInks® mimic the cell micro-environment and have tuneable properties to simulate the natural environment of all human tissues. Our PeptiGels® are specifically designed and tailored to overcome the key limitations with current biomaterials for regenerative medical applications. Our PeptiInks® are specifically designed to encapsulate and print cells with precise structural definition. Everything is 100% ethical, animal free and chemically defined, and are supplied with no batch-to-batch variability. This gives you the confidence to achieve reliable and consistent results every time, and with the adage of being clinically translatable, you have the potential to deliver life-changing therapies. Website: www.manchesterbiogel.com |
Merck WE ARE MERCK OUR LIFE SCIENCE BUSINESS ACCELERATES ACCESS TO HEALTH FOR PEOPLE EVERYWHERE. Website: https://www.sigmaaldrich.com |
Mimixbio ORCHESTRATE LIFE WITH SOUND - Next Generation Biofabrication mimiX biotherapeutics supports the research community with ACOUSTIC BIOPRINTING, a novel R&D platform to complement and advance the existing biofabrication methodologies. A powerful technology to push the frontiers of biofabrication. |
REGENHU REGENHU is a research driven, Swiss MedTech bioprinter pioneer committed to assisting the research and scientific communities by creating and developing state-of-the art bioprinting technologies to revolutionize medicine. Founded in 2007, the dynamic and rapidly expanding company is based in Villaz-St-Pierre, Switzerland, with offices in the United States, and distributors in Asia and Oceania. Website: www.regenhu.com |
Aspect Biosystems Aspect Biosystems is a Canadian biotechnology company combining the power of microfluidics and 3D bioprinting to fuel medical research and the development of bioprinted therapeutics. By adopting Aspect’s microfluidic 3D bioprinting platform and collaborating within Aspect’s network, researchers worldwide are accelerating the development and commercialization of 3D bioprinted tissues. In addition, Aspect is advancing its internal regenerative medicine programs focused on metabolic diseases and musculoskeletal injuries and disorders and partnering with key industry players to bring bioprinted therapeutics to the clinic. Website: www.aspectbiosystems.com |
Cellink Life Sciences Founded in 2016, CELLINK is a global life-science company that provides technologies, products and services to create, understand and master biology. With a focus on the application areas of bioprinting, analysis, and liquid handling and bioprocessing, the company develops and markets innovative technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical and cosmetic industries. CELLINK’s products are trusted by more than 1,800 laboratories, including ones at all the top 20 pharmaceutical companies, are being used in more than 60 countries, and have been cited in more than 200 publications. CELLINK is creating the future of medicine. Website: www.cellink.com |
Corbion Resorbable Polymers for Medical Implant Devices Corbion Biomaterials develops, manufactures and markets lactide and glycolide monomers and resorbable (co)polymers based on lactide, glycolide and caprolactone worldwide under the PURASORB® brand name. These polymers can be manufactured with any of the lactide isomers (L, D or DL). You can start your project assured that our polymers have already proven themselves as they are used extensively in medical device and pharmaceutical applications such as resorbable surgical sutures, orthopaedic implant devices and controlled drug delivery systems. Website: www.corbion.com/biomaterials |
Dunn Labortechnik Dunn Labortechnik has been in business for more than 38 years and is known for competent support, reliable service, high-quality products and fast delivery. Our carefully chosen portfolio for cell culture, micro and molecular biology, chemistry and life sciences includes laboratory equipment, consumables, and immunoreagents for research and production. Website: www.dunnlab.de |
XPECT INX XPECT-INX® is a spin-off project of Ghent University focussing on the commercialisation of materials and bio-inks for 3D bioprinting or biofabrication by utilizing decades of academic experience in the field of polymers and biomaterials. By offering a unique material portfolio with a diverse range of material properties, the applications become nearly limitless: the bio-inks can be applied for various tissue types ranging from soft tissues (e.g. adipose tissue, blood vessels, skin tissue) to hard tissues (e.g. Cartilage, bone, cornea) with applications in regenerative medicine or drug and cosmetics screening. Additionally, by offering a bio-ink portfolio suitable for multiple printing technologies, attainable resolutions range from hundreds of nanometers (multiphoton lithography), tens of micrometers (DLP printing) to hundreds of micrometers (syringe based printing). XPECT-INX® bio-inks are based on 3 core technologies: Our portfolio is subdivided in two categories: Discover our portfolio, including the first multiphoton lithography bio-ink suitable for high resolution cell encapsulation at our booth or at www.xpect-INX.com. Website: www.xpect-inx.com |
Lifecore Biomedical Do you need a source of Pharmaceutical Grade Sodium Hyaluronate for your TERM research and product development? For over 35 years, our hyaluronan has improved the lives of more than 100 million patients. Lifecore’s pharmaceutical grade hyaluronan is produced by bacterial fermentation in its U.S. based FDA registered/ISO 13485 certified-facility. Lifecore offers convenient quantities of sodium hyaluronate over a broad range of average molecular weights (5,000 Da. to 3M Da.) All its research lots of sodium hyaluronate are derived from pharmaceutical lots, are lot traceable, and come with a certificate of analysis. Website: www.lifecore.com |
Ocean TuniCell AS Founded upon more than 20 years of research expertise in the fields of marine molecular biology, biopolymer chemistry and engineering, we supply high purity and high quality tunicate nanocellulose to the biomedical market. We work towards a longer and healthier life for the human population. The business of Ocean TuniCell is to provide clinically relevant scaffold material that can bridge the gap between the research community and clinicians in order to facilitate the translational process in the field of regenerative medicine. Our core activity is the production and processing of medical grade tunicate cellulose nanofibrils, TUNICELL, with fibril dimensions similar to that of native collagen in extracellular matrices, providing excellent properties for 3D reconstruction of tissues and organs. We aim to be the preferred biomaterial supplier for in vitro and in vivo biomedical applications. Website: www.oceantunicell.com |
Nadir Plasma and Polymers Nadir Plasma and Polymers is an R&D company with more than 10 years experience in two innovative technologies: A Cold Atmospheric Plasma (CAP) proprietary technology for surface avctivation and cleaning, sterilization, and functional coating deposition. At the surface, by mean of our atmospheric plasma jet device, we allow you to sterilize and improve surface wettability, adhesion between materials and molecules and to modify the surface of your interest with specific chemical functionalities able to steer cell growth. Polymeric and ceramic thin film deposition are also possible. In the polymer bulk, by mean of our clean melt compounding technology, we are providing, custom bioactive polymer compounds like PCL/rGO, PCL/HA, PLA/HA, PEOTPBT and PolyActive ™ with active pharmaceutical ingredients (API) and other polymer compound realized on demand starting from different bioresorbable polymer and bioactive fillers . These bioactive materials will allow to realize additive manufactured parts with antimicrobial properties, cell growth differentiation properties, bone minerals properties and electroconductive properties. Finally, both technologies can be combined in 3D printing platforms to allow our customers to print advance polymer with intrinsic regenerative properties. 3D printing platforms, then, can be equipped with our plasma module in order to modify the surfaces of interest during the 3D printing process. Website: www.nadir-tech.it |
Readily3D Readily3D helps biologists push the frontiers of biofabrication. Our volumetric bioprinter, Tomolite, leverages a contactless tomographic illumination technology to shape sensitive cells and biomaterials into biological systems, without impairing their viability. Volumetric printing not only preserves cells but also makes research more efficient by simplifying design iterations and statistical studies. Reach out to us to know more! Website: www.readily3d.com |
REGENHU REGENHU is a research driven, Swiss MedTech bioprinter pioneer committed to assisting the research and scientific communities by creating and developing state-of-the art bioprinting technologies to revolutionize medicine. Founded in 2007, the dynamic and rapidly expanding company is based in Villaz-St-Pierre, Switzerland, with offices in the United States, and distributors in Asia and Oceania. Website: www.regenhu.com |
Regemat3D More information will be available soon. Website: www.regemat3d.com |
TissueLabs TissueLabs is the platform for creating organs and tissues in the lab. Our ECM-based hydrogels, MatriXpec™, are developed to offer tissue-specific microenvironments for 3D cell culture and 3D bioprinting. MatriXpec™ hydrogels allow running experiments in truly representative substrates that mimic the biological clues of the native extracellular matrix. They are available for 16 different tissues: Adipose, Bone, Brain, Cartilage, Colon, Intestine, Kidney, Liver, Lung, Muscle, Myocardium, Pancreas, Skin, Spleen, Stomach, and Vascular. Besides the conventional thermocrosslinkable MatriXpec™, we also offer it in combination with gelatin methacrylate (GelMA) - allowing photocrosslinking - and alginate/xanthan - allowing chemical crosslinking. For those working with epithelial tissues, we offer our proprietary platform, MatriWell™, cell culture inserts were designed for fabricating 3D epithelial barriers in vitro. They contain a hydrogel with tissue-specific extracellular matrix proteins so that when cells are cultured on MatriWell™ they are exposed to an air interface on their top and a near-liquid interface on their bottom, an "air-gel interface". This setup mimics the exact microenvironment cells would find in the native tissue. Thinking about the researchers willing to start working with 3D bioprinting, we developed TissueStart™, the most cost-effective 3D bioprinter on the market. TissueStart™ is constructed with premium plexiglass for high resistance, long durability, and easy cleaning. It weighs only 3.6kg and does not require air compressors to operate, presenting the smallest footprint on the market. TissueStart™ is also the only 3D bioprinter offering our exclusive Mixtrusor™ system for combining multiple bioinks, allowing the fabrication of complex 3D tissues Website: www.tissuelabs.com |